Iradimed Corp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 22,480 | 16,038 | 10,461 | 4,687 | 19,234 |
| Depreciation Amortization | 1,166 | 785 | 402 | 194 | 818 |
| Income taxes - deferred | 2,727 | 398 | 263 | 130 | -698 |
| Accounts receivable | -3,027 | -3,218 | -333 | -2,135 | 1,762 |
| Accounts payable and accrued liabilities | -76 | 437 | 5 | 694 | -862 |
| Other Working Capital | -4,345 | -397 | -620 | -1,493 | 3,750 |
| Other Operating Activity | 6,022 | 4,982 | 1,860 | 2,214 | 1,620 |
| Operating Cash Flow | $24,947 | $19,024 | $12,038 | $4,292 | $25,624 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,421 | -8,005 | -6,741 | -3,917 | -8,817 |
| Investing Cash Flow | $-8,421 | $-8,005 | $-6,741 | $-3,917 | $-8,817 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 0 | 0 | N/A | 29 |
| Dividend Paid | -15,040 | -6,486 | -4,323 | -2,162 | -13,677 |
| Other Financing Activity | -2,561 | -242 | -212 | -116 | -688 |
| Financing Cash Flow | $-17,601 | $-6,728 | $-4,535 | $-2,278 | $-14,336 |
| Beginning Cash Position | 52,234 | 52,234 | 52,234 | 52,234 | 49,762 |
| End Cash Position | 51,159 | 56,526 | 52,996 | 50,331 | 52,234 |
| Net Cash Flow | $-1,075 | $4,292 | $762 | $-1,903 | $2,472 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,947 | 19,024 | 12,038 | 4,292 | 25,624 |
| Capital Expenditure | -8,421 | -8,005 | -6,741 | -3,917 | -8,817 |
| Free Cash Flow | 16,526 | 11,020 | 5,297 | 375 | 16,807 |